STOCK TITAN

[144] Twist Bioscience Corp SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Twist Bioscience (TWST) filed a Form 144 reporting a proposed sale of 9,724 common shares with an aggregate market value of $312,986.38, to be sold through Fidelity Brokerage Services LLC on 10/06/2025 on NASDAQ. The shares were acquired on 10/01/2025 through restricted stock vesting and were paid as compensation.

The filing also discloses prior sales by the same person, Paula Green, totaling 3,201 shares sold across five trades between 08/04/2025 and 10/02/2025, generating $86,859.32 in gross proceeds. The company-wide share count reported in the notice is 60,360,925 shares outstanding. The filer certifies no undisclosed material adverse information.

Twist Bioscience (TWST) ha presentato un Form 144 riportando la vendita proposta di 9.724 azioni comuni con un valore di mercato complessivo di $312,986.38, da vendere tramite Fidelity Brokerage Services LLC il 10/06/2025 su NASDAQ. Le azioni sono state acquistate il 10/01/2025 tramite vesting di azioni soggette a restrizioni e sono state pagate come compenso.

La presentazione segnala anche vendite precedenti da parte della stessa persona, Paula Green, per un totale di 3,201 azioni vendute in cinque operazioni tra 08/04/2025 e 10/02/2025, generando $86,859.32 di proventi lordi. Il numero di azioni della società riportato nel notificante è 60,360,925 azioni in circolazione. Il dichiarante certifica che non ci sono informazioni avverse material non divulgate.

Twist Bioscience (TWST) presentó un Formulario 144 informando una venta propuesta de 9,724 acciones ordinarias con un valor de mercado agregado de $312,986.38, para ser vendidas a través de Fidelity Brokerage Services LLC en 10/06/2025 en NASDAQ. Las acciones se adquirieron el 10/01/2025 mediante vesting de acciones restringidas y se pagaron como compensación.

La presentación también divulga ventas anteriores por la misma persona, Paula Green, por un total de 3,201 acciones vendidas en cinco operaciones entre 08/04/2025 y 10/02/2025, generando $86,859.32 en ingresos brutos. El recuento total de acciones de la empresa reportado en el aviso es de 60,360,925 acciones en circulación. El responsable certifica que no existen informaciones adversas materiales no divulgadas.

Twist Bioscience (TWST)가 제안 매각을 보고하는 Form 144를 제출했습니다. 9,724 주의 보통주를 총 시가 $312,986.38로 Fidelity Brokerage Services LLC를 통해 2025-10-06에 NASDAQ에서 매도할 예정입니다. 주식은 2025-10-01제한 주식 가속(vesting)으로 취득되었고 보상으로 지급되었습니다.

또한 제출서는 Paula Green이라는 동일인이 2025-08-04과 2025-10-02 사이의 다섯 거래에서 총 3,201주를 매도한 이전 매매를 밝히고 있으며, $86,859.32의 총수익을 발생시켰습니다. 공시에서 보고된 회사의 전체 주식 수는 60,360,925주가 유통 중입니다. 제출인은 비공개의 중요한 악재 정보가 없다고 인증합니다.

Twist Bioscience (TWST) a déposé un Form 144 signalant une vente proposée de 9 724 actions ordinaires d'une valeur marchande globale de $312 986,38, à vendre via Fidelity Brokerage Services LLC le 10/06/2025 sur le NASDAQ. Les actions ont été acquises le 01/10/2025 par le biais d'un vesting d'actions restreintes et ont été versées comme rémunération.

Le dossier divulge également des ventes antérieures par la même personne, Paula Green, totalisant 3 201 actions vendues au cours de cinq transactions entre le 04/08/2025 et le 02/10/2025, générant $86 859,32 de produits bruts. Le nombre d'actions de l'entreprise rapporté dans l'avis est de 60 360 925 actions en circulation. Le déclarant certifie qu'il n'y a pas d'informations défavorables matérielles non divulguées.

Twist Bioscience (TWST) hat ein Formular 144 eingereicht und meldet einen vorgeschlagenen Verkauf von 9.724 Stammaktien mit einem Gesamtmarktwert von $312.986,38, der über Fidelity Brokerage Services LLC am 10.06.2025 an der NASDAQ verkauft werden soll. Die Aktien wurden am 01.10.2025 durch Restricted Stock Vesting erworben und wurden als Vergütung ausgezahlt.

Die Einreichung disclose auch frühere Verkäufe derselben Person, Paula Green, insgesamt 3.201 Aktien, die in fünf Trades zwischen dem 04.08.2025 und dem 02.10.2025 verkauft wurden, und erzielten $86.859,32 Bruttoerträge. Die im Hinweis gemeldete Unternehmensaktienanzahl beträgt 60.360.925 ausstehende Aktien. Der Einreicher bestätigt, dass keine undisclosed material adverse information vorliegt.

Twist Bioscience (TWST) تقدّمت بنموذج 144 للإبلاغ عن بيع مقترح لـ 9,724 سهماً عاديًا بقيمة سوقية إجمالية قدرها $312,986.38، ليتم بيعها من خلال Fidelity Brokerage Services LLC في 10/06/2025 في NASDAQ. تم الحصول على الأسهم في 01/10/2025 من خلال vesting الأسهم المقيدة ودفعت كتعويض.

كما يكشف الإبلاغ عن مبيعات سابقة من نفس الشخص، Paula Green، بإجمالي 3,201 سهم تم بيعها عبر خمس تعاملات بين 08/04/2025 و 10/02/2025، محققة عوائد إجمالية قدرها $86,859.32. عدد أسهم الشركة المبلغ عنه في الإشعار هو 60,360,925 سهم قائم. يؤكد المبلغ أن لا توجد معلومات ضارة جوهرية غير معلنة.

Twist Bioscience (TWST) 已提交 Form 144,报告拟议出售 9,724 股普通股,合计市值 $312,986.38,将于 NASDAQ2025-10-06 通过 Fidelity Brokerage Services LLC 出售。 这批股票于 2025-10-01 通过 restricted stock vesting 获取,并作为 薪酬 支付。

该备案还披露同一人 Paula Green 在 2025-08-04 至 2025-10-02 之间进行的五笔交易,总计卖出 3,201 股,毛收入 $86,859.32。公告中报告的公司总股本为 60,360,925 股在外流通。备案人证明不存在未披露的重大不利信息。

Positive
  • Restricted stock vesting shows use of equity to compensate employees, aligning pay with company ownership
  • Brokered sale via Fidelity uses an established brokerage channel, suggesting standard execution
Negative
  • Planned sale of 9,724 shares (aggregate $312,986.38) will increase share supply on 10/06/2025
  • Insider sold 3,201 shares for $86,859.32 in the prior three months, indicating ongoing monetization of holdings

Insights

TL;DR: An insider sale after recent restricted stock vesting increases available shares but appears routine.

The transaction shows 9,724 shares vesting on 10/01/2025 and a planned sale on 10/06/2025 through Fidelity, with an aggregate market value of $312,986.38. That links compensation vesting directly to immediate disposition of shares rather than long-term holding.

The seller previously sold 3,201 shares for $86,859.32 between 08/04/2025 and 10/02/2025, indicating repeated monetization of equity. Monitor near-term volume on NASDAQ around 10/06/2025 and any disclosed trading-plan dates to assess whether sales follow a structured plan or ad-hoc decisions.

Twist Bioscience (TWST) ha presentato un Form 144 riportando la vendita proposta di 9.724 azioni comuni con un valore di mercato complessivo di $312,986.38, da vendere tramite Fidelity Brokerage Services LLC il 10/06/2025 su NASDAQ. Le azioni sono state acquistate il 10/01/2025 tramite vesting di azioni soggette a restrizioni e sono state pagate come compenso.

La presentazione segnala anche vendite precedenti da parte della stessa persona, Paula Green, per un totale di 3,201 azioni vendute in cinque operazioni tra 08/04/2025 e 10/02/2025, generando $86,859.32 di proventi lordi. Il numero di azioni della società riportato nel notificante è 60,360,925 azioni in circolazione. Il dichiarante certifica che non ci sono informazioni avverse material non divulgate.

Twist Bioscience (TWST) presentó un Formulario 144 informando una venta propuesta de 9,724 acciones ordinarias con un valor de mercado agregado de $312,986.38, para ser vendidas a través de Fidelity Brokerage Services LLC en 10/06/2025 en NASDAQ. Las acciones se adquirieron el 10/01/2025 mediante vesting de acciones restringidas y se pagaron como compensación.

La presentación también divulga ventas anteriores por la misma persona, Paula Green, por un total de 3,201 acciones vendidas en cinco operaciones entre 08/04/2025 y 10/02/2025, generando $86,859.32 en ingresos brutos. El recuento total de acciones de la empresa reportado en el aviso es de 60,360,925 acciones en circulación. El responsable certifica que no existen informaciones adversas materiales no divulgadas.

Twist Bioscience (TWST)가 제안 매각을 보고하는 Form 144를 제출했습니다. 9,724 주의 보통주를 총 시가 $312,986.38로 Fidelity Brokerage Services LLC를 통해 2025-10-06에 NASDAQ에서 매도할 예정입니다. 주식은 2025-10-01제한 주식 가속(vesting)으로 취득되었고 보상으로 지급되었습니다.

또한 제출서는 Paula Green이라는 동일인이 2025-08-04과 2025-10-02 사이의 다섯 거래에서 총 3,201주를 매도한 이전 매매를 밝히고 있으며, $86,859.32의 총수익을 발생시켰습니다. 공시에서 보고된 회사의 전체 주식 수는 60,360,925주가 유통 중입니다. 제출인은 비공개의 중요한 악재 정보가 없다고 인증합니다.

Twist Bioscience (TWST) a déposé un Form 144 signalant une vente proposée de 9 724 actions ordinaires d'une valeur marchande globale de $312 986,38, à vendre via Fidelity Brokerage Services LLC le 10/06/2025 sur le NASDAQ. Les actions ont été acquises le 01/10/2025 par le biais d'un vesting d'actions restreintes et ont été versées comme rémunération.

Le dossier divulge également des ventes antérieures par la même personne, Paula Green, totalisant 3 201 actions vendues au cours de cinq transactions entre le 04/08/2025 et le 02/10/2025, générant $86 859,32 de produits bruts. Le nombre d'actions de l'entreprise rapporté dans l'avis est de 60 360 925 actions en circulation. Le déclarant certifie qu'il n'y a pas d'informations défavorables matérielles non divulguées.

Twist Bioscience (TWST) hat ein Formular 144 eingereicht und meldet einen vorgeschlagenen Verkauf von 9.724 Stammaktien mit einem Gesamtmarktwert von $312.986,38, der über Fidelity Brokerage Services LLC am 10.06.2025 an der NASDAQ verkauft werden soll. Die Aktien wurden am 01.10.2025 durch Restricted Stock Vesting erworben und wurden als Vergütung ausgezahlt.

Die Einreichung disclose auch frühere Verkäufe derselben Person, Paula Green, insgesamt 3.201 Aktien, die in fünf Trades zwischen dem 04.08.2025 und dem 02.10.2025 verkauft wurden, und erzielten $86.859,32 Bruttoerträge. Die im Hinweis gemeldete Unternehmensaktienanzahl beträgt 60.360.925 ausstehende Aktien. Der Einreicher bestätigt, dass keine undisclosed material adverse information vorliegt.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What is TWST filing in this Form 144?

The filing reports a proposed sale of 9,724 common shares worth $312,986.38 to be sold on 10/06/2025 on NASDAQ through Fidelity Brokerage Services.

How were the 9,724 TWST shares acquired?

The shares were acquired on 10/01/2025 via restricted stock vesting and paid as compensation.

Has the filer sold TWST shares recently?

Yes. Paula Green sold 3,201 shares across five trades from 08/04/2025 to 10/02/2025, receiving $86,859.32 in gross proceeds.

How many TWST shares are outstanding according to the filing?

The filing lists 60,360,925 shares outstanding.

Through which broker will the proposed TWST sale be executed?

The broker named is Fidelity Brokerage Services LLC (address shown in the filing).
Twist Bioscience

NASDAQ:TWST

TWST Rankings

TWST Latest News

TWST Latest SEC Filings

TWST Stock Data

1.92B
59.19M
1.86%
115.89%
16.96%
Diagnostics & Research
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO